Piet L. C. M. Van Riel
#185,360
Most Influential Person Now
Piet L. C. M. Van Riel's AcademicInfluence.com Rankings
Piet L. C. M. Van Rielbiology Degrees
Biology
#15578
World Rank
#19595
Historical Rank
Computational Biology
#375
World Rank
#377
Historical Rank
Genetics
#1838
World Rank
#1954
Historical Rank
Molecular Biology
#2698
World Rank
#2739
Historical Rank
Download Badge
Biology
Piet L. C. M. Van Riel's Degrees
- PhD Biomedical Sciences University of Amsterdam
- Masters Biomedical Sciences University of Amsterdam
Why Is Piet L. C. M. Van Riel Influential?
(Suggest an Edit or Addition)Piet L. C. M. Van Riel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci (2010) (1285)
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (2010) (377)
- Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial (2002) (267)
- Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. (1992) (229)
- PROGNOSTIC FACTORS FOR RADIOGRAPHIC DAMAGE AND PHYSICAL DISABILITY IN EARLY RHEUMATOID ARTHRITIS. A PROSPECTIVE FOLLOW-UP STUDY OF 147 PATIENTS (1992) (221)
- Quality of life 3 (1993) (214)
- Rheumatoid arthritis measures: Disease activity score (DAS), disease activity score-28 (DAS28), rapid assessment of disease activity in rheumatology (RADAR), and rheumatoid arthritis disease activity index (RADAI) (2003) (189)
- Induction of nocebo and placebo effects on itch and pain by verbal suggestions (2011) (158)
- ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials : Part 3: Rheumatoid Arthritis: Response (1998) (139)
- Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. (1988) (123)
- Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification) (1995) (111)
- The development of the disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28). (2014) (111)
- Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis. (1991) (107)
- Clinical outcome measures in rheumatoid arthritis (2000) (104)
- PROVISIONAL GUIDELINES FOR MEASURING DISEASE ACTIVITY IN CLINICAL TRIALS ON RHEUMATOID ARTHRITIS (1992) (102)
- The role of TNF- a in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk (2007) (85)
- Sustained Beneficial Effects of a Protocolized Treat‐to‐Target Strategy in Very Early Rheumatoid Arthritis: Three‐Year Results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort (2013) (79)
- Development and Validation of Response Criteria in Rheumatoid Arthritis: Steps Towards an International Consensus on Prognostic Markers (1996) (78)
- An increased risk of non‐melanoma skin cancer during TNF‐inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease‐related factors (2015) (57)
- Association Between Fatigue and Pain in Rheumatoid Arthritis: Does Pain Precede Fatigue or Does Fatigue Precede Pain? (2013) (55)
- Additive value for ultrasonographic signal in a screening algorithm for patients presenting with acute mono-/oligoarthritis in whom gout is suspected (2014) (54)
- Relationship Between Objectively Assessed Physical Activity and Fatigue in Patients With Rheumatoid Arthritis: Inverse Correlation of Activity and Fatigue (2014) (52)
- What patients think about E-health: patients’ perspective on internet-based cognitive behavioral treatment for patients with rheumatoid arthritis and psoriasis (2013) (49)
- Cognitive, behavioral and physiological reactivity to pain as a predictor of long-term pain in rheumatoid arthritis patients (2001) (44)
- Sensitivity of a Dutch Health Assessment Questionnaire in a Trial Comparing Hydroxychloroquine vs. Sulphasalazine (1990) (43)
- Rheumatoid Arthritis Measures. (2003) (38)
- CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement (2006) (37)
- Screening for pain-persistence and pain-avoidance patterns in fibromyalgia (2008) (37)
- EFFICACY AND TOLERABILITY OF WEEKLY SUBCUTANEOUS INJECTIONS OF THE FULLY HUMAN ANTI-TNF-ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID ARTHRITIS-RESULTS OF A PHASE I STUDY (1998) (35)
- Sensitivity to itch and pain in patients with psoriasis and rheumatoid arthritis (2013) (33)
- Uncoupling of inflammation and destruction in rheumatoid arthritis : Myth or reality? (2005) (28)
- Long-Term Usage and Side-Effect Profile of Sulphasalazine in Rheumatoid Arthritis (1995) (26)
- FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus (2007) (25)
- The Initial Validation of a Markov Model for the Economic Evaluation of (New) Treatments for Rheumatoid Arthritis (2012) (25)
- A SINGLE DOSE PLACEBO CONTROLLED PHASE I STUDY OF THE FULLY HUMAN ANTI-TNF ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID ARTHRITIS (1998) (24)
- The psychophysiological stress response in psoriasis and rheumatoid arthritis (2014) (23)
- Area under the curve for the American College of Rheumatology improvement criteria: a valid addition to existing criteria in rheumatoid arthritis? (2001) (20)
- Clinical assessment and clinical trials in rheumatoid arthritis. (1994) (19)
- Early treatment of rheumatoid arthritis: rationale, evidence, and implications (1998) (19)
- Evaluation of early rheumatoid arthritis disease activity and outcome (1997) (15)
- Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data (2010) (15)
- Rheumatoid arthritis: Understanding joint damage and physical disability in RA (2011) (14)
- American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis: comment on the article by Felson et al. (1996) (14)
- Management of Adverse Effects of Disease-Modifying Antirheumatic Drugs (1995) (14)
- Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients’ Burden of Disease (2018) (11)
- Leflunomide in combination therapy (2004) (10)
- Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis (2014) (9)
- DAS 28 : a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis (9)
- The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice (2006) (9)
- Recurrent and migratory reflex sympathetic dystrophy syndrome (1992) (8)
- How to assess fatigue in rheumatoid arthritis: Validity and reliability of the checklist individual strength. (2008) (7)
- Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus (2011) (7)
- Response criteria for slow acting antirheumatic drugs. (1990) (6)
- Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis (1986) (6)
- Serum gold concentrations during treatment with auranofin (1987) (6)
- A higher rate of serious infections in patients treated with TNF blocking agents (2006) (6)
- Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change (2015) (6)
- The Inhibitory FcγIIb Receptor Dampens Toll-like Receptor 4 Mediated Immune Responses and is Selectively Up Regulated on Dendritic Cells from Rheumatoid Arthritis Patients with Quiescent Disease (2009) (5)
- Randomized trial of stopping TNF-inhibitors in rheumatoid arthrisis: patients with stable low disease activity in the Netherlands (2014) (5)
- An economic evaluation of stopping versus continuing TNF-inhibitor treatment in rheumatoid arthritis patients in remission or low disease activity : results from the POET randomized trial (2018) (5)
- Report of the EULAR Standing Committee for International clinical Studies Including therapeutic Trials (ESCISIT) (2001) (5)
- Mode Of Action Change Not Necessary After Failing The First Tumor-necrosisfactor Inhibitor (2013) (4)
- EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT) (2003) (4)
- Achievement of sustained low disease activity state predicts the absence of structural damage progression in patients with Rheumatoid arthritis: insights from the abatacept database. (2009) (4)
- Rheumatoid arthritis-changing theories and treatment modalities (1995) (4)
- Leflunomide improves the clinical response in patients with active rheumatoid arthritis treated with methotrexate. (2003) (4)
- Muscle ultrasonography is a potential tool for detecting fasciitis in dermatomyositis and polymyositis: comment on the article by Yoshida et al (2017) (3)
- Currently used second-line agents: do they control the disease course? (1997) (3)
- The influence of sulfasalazine, methotrexate and the combination of both on plasma homocysteine levels in patients with rheumatoid arthritis (1997) (3)
- Initial combination therapy with adalimumab and methotrexate sustains clinical remission and response for early RA patients treated through year 5 (2008) (3)
- Prevalence and severity of fatigue in patients with rheumatoid arthritis (2004) (3)
- Is DAS28-remission good enough? Disease activity and functionality in rheumatiod arthritis, results of the DREAM remission induction cohort (2010) (2)
- Physical and psychological aspects of fatigue in rheumatoid arthritis: A comparison of RA patients with and without fatigue. (2008) (2)
- Nephrotic syndrome as a complication of anti-TNFin a patient with rheumatoid arthritis (2003) (2)
- Disease assessment in rheumatoid arthritis. (1989) (2)
- Do Disease-Modifying Antirheumatic Drugs Actually Modify Disease Course in Rheumatoid Arthritis? (1994) (2)
- Can psychological interventions alter the physiological stress response of patients with rheumatoid arthritis (2011) (2)
- F.122. Toll Like Receptor 2 Promotes Th2/Th17 Responses via TLR4 and TLR8 by Human Dendritic Cells by Abrogating the Type 1 Interferon Amplification Loop (2009) (2)
- Remission in daily clinical practice: excellent results after one year of tight control in very early rheumatiod arthritis, results of the DREAM remission induction cohort (2010) (2)
- Effectiveness of Switch to a Second Anti-TNF-α in Primary Nonresponders, Secondary Nonresponders and Failure Due to Adverse Events (2007) (2)
- Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study (1984) (2)
- COMMENT ON : AMERICAN COLLEGE OF RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID ARTHRITIS. AUTHOR'S REPLY (1996) (1)
- Rheumatoid arthritis: new trends in therapy. (1995) (1)
- Radiological progression in very early rheumatoid arthritis, results of the DREAM remission induction cohort (2010) (1)
- One-year results after transitioning from Etanercept Originator to Biosimilar in a shared decision-making promoting setting in rheumatology. (2020) (1)
- Indices of disease activity in rheumatoid arthritis (1995) (1)
- Studies on auranofin and aurothioglucose in rheumatoid arthritis (1983) (1)
- Are prognostic factors in rheumatoid arthritis of any use in daily clinical practice (2002) (1)
- Comment on the article by Felson et al. (1991) (1)
- Rheumatoid Arthritis Using Disease Modifying Antirheumatic Drugs Adherence Rates and Associations with Nonadherence in Patients with (2009) (1)
- Systematic review of patientreported patientreported patientreported outcome measures ( PROMs ) for assessing disease activity in rheumatoid arthritis (2018) (1)
- Sustained clinical remission and response for early RA patients with adalimumab and methotrexate initial combination therapy: 5-year results of the PREMIER trial. (2009) (1)
- Third International Symposium for health professionals in rheumatology (1990) (1)
- Chloroquine interaction with inflammatory human polymorphonuclear leucocytes (1988) (1)
- Tailored treatment: it's not what you think it is. Comment on the article by van Koulil et al. (2011) (1)
- Responsiveness of the EQ-5D and SF-6D to improvement in patients with Rheumatoid Arthritis receiving a first TNF-blocker: results of the DREAM registry (2010) (1)
- Tailored cognitive-behavioral therapy for fibromyalgia: A randomized, controlled trial: (524362011-090) (2013) (0)
- severe systemic sclerosis haematopoietic stem cell transplantation for Long-term follow-up results after autologous (2008) (0)
- Generalized Urticaria1 Eruption during Azathioprine Treat m en t f o r R h e u m at o i d Art h r i t i s A Case Report and Review of the Literature (1990) (0)
- Side effects of cytokine blocking strategies (2007) (0)
- Item response theory analyses of joint counts in rheumatoid arthritis (2011) (0)
- Treatment of rheumatoid arthritis: towards disease control? (1995) (0)
- How to reduce costs of biological treatments in patients with Rheumatoid Arthritis: The Dutch experience (2016) (0)
- Effectiveness Of Tocilizumab In Monotherapy and In Combination With Different Synthetic Dmards: A Registry-Based Comparison Study (2013) (0)
- Tight control is infrequently applied in daily clinical practice among patients treated with tnf blockers, results from the dream registry (2010) (0)
- 2008for the treatment of rheumatic diseases, Updated consensus statement on biological (2008) (0)
- Adherence aan een treat-to-target strategie in vroege rheumatoїde artritis: resultaten van het DREAM register inductie cohort (2012) (0)
- [Non-melanoma skin cancer during treatment with TNF inhibitors in psoriasis and rheumatoid arthritis] (2015) (0)
- Abstracts of Dutch Ph.D. Theses (1984) (0)
- F175 ROLE OF NEGATIVE AND POSITIVE EMOTIONS IN SENSITIVITY TO PAIN AND ITCH (2011) (0)
- Internet-Specific Therapeutic Relationship Questionnaire (2017) (0)
- Improvement criteria—clinical and statistical significance: Comment on the article by Pincus and Stein (2000) (0)
- Grave's Disease, rheumatoid arthritis, and anti-tumor necrosis factor-alpha therapy reply. (2009) (0)
- Disappointing responsiveness of the EQ-5D and the SF-6D to detect improvement in patients receiving a first TNF-blocker: results of the DREAM registry. (2010) (0)
- Report of the 23rd World Congress on Psychosomatic Medicine, Glasgow, UK, 2015 (2015) (0)
- Thematic stream: co-morbidity (PP59–PP86) PP59. A Single Dose of Indomethacin does not Prolong Premotor Reaction Time in Young Healthy Adults: A Randomised, Placebo Controlled, Double-Blind, Cross-Over Study (2011) (0)
- Small ceiling effects of the generic utility instrument EQ-5D in Rheumatoid Arthritis patients receiving a first TNF-blocker: results of the DREAM registry. (2010) (0)
- for the treatment of rheumatic diseases, 2006 Updated consensus statement on biological agents (2007) (0)
- The agreement with the dutch regulation for reimbursement of anti-TNFa for patients with rheumatoid arthritis in daily clinical practice discussed (2007) (0)
- A comparison of the effectiveness of TNF Alpha blocking agents in the treatment of rheumatoid arthritis between randomized controlled trials and Dutch observational data (2006) (0)
- Cardiovascular risk factors in RA and their modulation during TNF-alpha blockade. (2005) (0)
- Fecal blood loss comparing beta-cyclodextrine-piroxicam with naproxen in a 48-week study (2000) (0)
- 557 EVIDENCE-BASED TAILORED CONSERVATIVE TREATMENT OF KNEE AND HIP OA: BETWEEN KNOWING AND DOING (2010) (0)
- Co-morbidity in Rheumatoid arthritis patients (2004) (0)
- association of Actometer Assessed Physical Activity and Fatigue in Patients with Rheumatoid Arthritis: Patients with a Lower Daily Activity Have More Fatigue. : 1232 (2012) (0)
- REM ISSIONS IN PATIENTS WITH RHEUM ATOID ARTHRITIS (1995) (0)
- Confirmatory Factor Analysis of the AIMS2-SF in Patients with Rheumatoid Arthritis (2007) (0)
- The Journal of Rheumatology with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in Neutrophil migration and production of reactive oxygen species during treatment (2003) (0)
- Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register RHEUMATOLOGY (2010) (0)
- A prospective analysis of risk factors for the discontinuation of second-line antirheumatic drugs (1993) (0)
- Safety of biological agents in patients with active rheumatoid arthritis. (2007) (0)
- Rheumatoid Arthritis : Two Case Reports (2019) (0)
- In search of a classification system for forefoot deformity in patients with rheumatoid arthritis (2002) (0)
- Investigating the role of CXCL4 in Systemic Sclerosis and its potential as a new therapeutic target (2011) (0)
- CHRONIC POLYARTHRLTIS DUE TO PSEUDOMONAS AERUGINOSA (1993) (0)
- Abstracts of papers (2005) (0)
- PMS68 ANTI-TUMOUR NECROSIS FACTOR-α INHIBITOR DOSE CHANGES IN RHEUMATOID ARTHRITIS PATIENTS IN A PROSPECTIVE PATIENT REGISTRY SETTING (2008) (0)
- The Sex-Determining Region Y Box 6 Locus (2012) (0)
- Equal drug survival for methotrexate and sulfasalazine in a dutch inception cohort of early RA patients (1997) (0)
- Patient-Reported Outcomes Measurement Information System Physical Function Item Bank--Rheumatoid Arthritis (2021) (0)
- Quiescent Disease from Rheumatoid Arthritis Patients with Selectively Up-regulated on Dendritic Cells TLR4-Mediated Immune Responses and Is IIb Receptor Dampens g The Inhibitory Fc (2009) (0)
- The effect of a joint protection programme on dexterity in patients with early rheumatoid arthritis (2002) (0)
- Diagnosing iron deficiency anemia in patients with rheumatoid arthritis (2009) (0)
- Adherence to a Treat-to-Target Strategy in Early Rheumatoid Arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort (2012) (0)
- Long-term radiographic progression in treated rheumatoid arthritis. (1990) (0)
- THU0169 Can Baseline (Anti-)Infliximab Serum Trough Levels Predict Successful Down-Titration or Discontinuation of Infliximab in Rheumatoid Arthritis Patients with Long Term Low Disease Activity? (2013) (0)
- REPRINTED WITH PERMISSION OF IASP - PAIN 158 (2017) 868–878: A tailored-guided internet-based cognitive-behavioralintervention for patients with rheumatoid arthritis asan adjunct to standard rheumatological care: results ofa randomized controlled trial (2017) (0)
- treatment modal it ies (1995) (0)
- Disease-modifying drug series / Series (1999) (0)
This paper list is powered by the following services:
